Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Cayman Latanoprostene Bunod

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    evonik-m-2025-09-08

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Menu

    Latanoprostene Bunod

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,774,105Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Valeant Canada LP / Valeant Canada S.E.C.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Valeant Canada LP / Valeant ...

    LATANOPROSTENE BUNOD
    arrow
    BIOHK2025
    Not Confirmed

    Valeant Canada LP / Valeant Canada S.E.C.

    Country
    arrow
    BIOHK2025
    Not Confirmed

    Patent Expiration Date : 2024-12-27

    Date Granted : 2011-02-22

    LATANOPROSTENE BUNOD

    Brand Name : VYZULTA

    Patent Number : 2551409

    Filing Date : 2004-12-27

    Strength per Unit : 0.24 mg / mL

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : OPHTHALMIC

    Patent Expiration Date : 2024-12-27

    Date Granted : 2011-02-22

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF